BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24428642)

  • 1. A novel gene expression signature in peripheral blood mononuclear cells for early detection of colorectal cancer.
    Nichita C; Ciarloni L; Monnier-Benoit S; Hosseinian S; Dorta G; Rüegg C
    Aliment Pharmacol Ther; 2014 Mar; 39(5):507-17. PubMed ID: 24428642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a 29-gene panel in peripheral blood mononuclear cells for the detection of colorectal cancer and adenomas using high throughput real-time PCR.
    Ciarloni L; Hosseinian S; Monnier-Benoit S; Imaizumi N; Dorta G; Ruegg C;
    PLoS One; 2015; 10(4):e0123904. PubMed ID: 25876024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation patterns in blood of patients with colorectal cancer and adenomatous colorectal polyps.
    Cassinotti E; Melson J; Liggett T; Melnikov A; Yi Q; Replogle C; Mobarhan S; Boni L; Segato S; Levenson V
    Int J Cancer; 2012 Sep; 131(5):1153-7. PubMed ID: 22020530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Clinical Validation of a Blood Test Based on 29-Gene Expression for Early Detection of Colorectal Cancer.
    Ciarloni L; Ehrensberger SH; Imaizumi N; Monnier-Benoit S; Nichita C; Myung SJ; Kim JS; Song SY; Kim TI; van der Weg B; Meier R; Borovicka J; Beglinger C; Vallet C; Maerten P; Rüegg C; Dorta G
    Clin Cancer Res; 2016 Sep; 22(18):4604-11. PubMed ID: 27126992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applying simple linear combination, multiple logistic and factor analysis methods for candidate fecal bacteria as novel biomarkers for early detection of adenomatous polyps and colon cancer.
    Rezasoltani S; Sharafkhah M; Asadzadeh Aghdaei H; Nazemalhosseini Mojarad E; Dabiri H; Akhavan Sepahi A; Modarressi MH; Feizabadi MM; Zali MR
    J Microbiol Methods; 2018 Dec; 155():82-88. PubMed ID: 30439465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel method for screening colorectal cancer by infrared spectroscopy of peripheral blood mononuclear cells and plasma.
    Barlev E; Zelig U; Bar O; Segev C; Mordechai S; Kapelushnik J; Nathan I; Flomen F; Kashtan H; Dickman R; Madhala-Givon O; Wasserberg N
    J Gastroenterol; 2016 Mar; 51(3):214-21. PubMed ID: 26112122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CA11-19: a tumor marker for the detection of colorectal cancer.
    Overholt BF; Wheeler DJ; Jordan T; Fritsche HA
    Gastrointest Endosc; 2016 Mar; 83(3):545-51. PubMed ID: 26318832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TFPI2 and NDRG4 gene promoter methylation analysis in peripheral blood mononuclear cells are novel epigenetic noninvasive biomarkers for colorectal cancer diagnosis.
    Bagheri H; Mosallaei M; Bagherpour B; Khosravi S; Salehi AR; Salehi R
    J Gene Med; 2020 Aug; 22(8):e3189. PubMed ID: 32196834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A plasma microRNA panel for early detection of colorectal cancer.
    Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H
    Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Natural Killer Cell Activity and Colorectal Cancer in High-Risk Subjects Undergoing Colonoscopy.
    Jobin G; Rodriguez-Suarez R; Betito K
    Gastroenterology; 2017 Oct; 153(4):980-987. PubMed ID: 28625834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
    Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
    Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of plasma epigenetic changes of five major genes involved in the pathogenesis of colorectal cancer.
    Pack SC; Kim HR; Lim SW; Kim HY; Ko JY; Lee KS; Hwang D; Park SI; Kang H; Park SW; Hong GY; Hwang SM; Shin MG; Lee S
    Int J Colorectal Dis; 2013 Jan; 28(1):139-47. PubMed ID: 22990173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and validation of a blood-based 18-gene expression signature in colorectal cancer.
    Xu Y; Xu Q; Yang L; Ye X; Liu F; Wu F; Ni S; Tan C; Cai G; Meng X; Cai S; Du X
    Clin Cancer Res; 2013 Jun; 19(11):3039-49. PubMed ID: 23536436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the presence of adenomatous polyps during colonoscopy with National Cancer Institute Colorectal Cancer Risk-Assessment Tool.
    Tariq H; Kamal MU; Patel H; Patel R; Ameen M; Elona S; Khalifa M; Azam S; Zhang A; Kumar K; Baiomi A; Shaikh D; Makker J
    World J Gastroenterol; 2018 Sep; 24(34):3919-3926. PubMed ID: 30228785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Fecal M2PK as a Diagnostic Marker in Colorectal Cancer.
    Dabbous HK; Mohamed YAE; El-Folly RF; El-Talkawy MD; Seddik HE; Johar D; Sarhan MA
    J Gastrointest Cancer; 2019 Sep; 50(3):442-450. PubMed ID: 29626277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer.
    Rahier JF; Druez A; Faugeras L; Martinet JP; Géhénot M; Josseaux E; Herzog M; Micallef J; George F; Delos M; De Ronde T; Badaoui A; D'Hondt L
    Clin Epigenetics; 2017; 9():53. PubMed ID: 28515797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplex screening of 275 plasma protein biomarkers to identify a signature for early detection of colorectal cancer.
    Bhardwaj M; Weigl K; Tikk K; Benner A; Schrotz-King P; Brenner H
    Mol Oncol; 2020 Jan; 14(1):8-21. PubMed ID: 31652396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression analysis using a highly sensitive DNA microarray for colorectal cancer screening.
    Koga Y; Yamazaki N; Takizawa S; Kawauchi J; Nomura O; Yamamoto S; Saito N; Kakugawa Y; Otake Y; Matsumoto M; Matsumura Y
    Anticancer Res; 2014 Jan; 34(1):169-76. PubMed ID: 24403458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cumulative evaluation of a quantitative immunochemical fecal occult blood test to determine its optimal clinical use.
    Rozen P; Comaneshter D; Levi Z; Hazazi R; Vilkin A; Maoz E; Birkenfeld S; Niv Y
    Cancer; 2010 May; 116(9):2115-25. PubMed ID: 20186820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiplex quantitation of 270 plasma protein markers to identify a signature for early detection of colorectal cancer.
    Bhardwaj M; Weigl K; Tikk K; Holland-Letz T; Schrotz-King P; Borchers CH; Brenner H
    Eur J Cancer; 2020 Mar; 127():30-40. PubMed ID: 31972396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.